Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：200901071092131737
Update date: Mar. 19, 2025 Takeuchi Kengo
タケウチ ケンゴ | Takeuchi Kengo
ClipsMISC (32)
- 西村 友美, 垣内 伸之, 吉田 健一, 桜井 孝規, 片岡 竜貴, 澤田 守男, 竹内 康英, 前田 紘奈, 滝田 順子, 宮野 悟, et al. 正常組織におけるクローン進化 乳癌の発生に至るクローン進化の歴史(Clonal evolution in normal tissues Evolutionary histories of breast cancer and related clones). 日本癌学会総会記事. 2023. 82回. 1118-1118
- 西村 友美, 垣内 伸之, 吉田 健一, 桜井 孝規, 片岡 竜貴, 澤田 守男, 竹内 康英, 前田 紘奈, 馬場 郷子, 滝田 順子, et al. 正常およびがん組織におけるクローン進化 乳管上皮細胞から乳癌へ至るクローン進化(Clonal evolution of mammary epithelial cells into breast cancers). 日本癌学会総会記事. 2022. 81回. S23-5
- 大迫 智, Luangxay Thitsamay, 馬場 郷子, 上野 貴之, 大野 真司, 秋山 太, 竹内 賢吾. 乳腺分泌癌の診断におけるPan-TRK免疫染色の有用性. 日本病理学会会誌. 2020. 109. 1. 312-312
- Tomo Osako, Satoko Baba, Hiroko Nagano, Takayuki Ueno, Shinji Ohno, Futoshi Akiyama, Kengo Takeuchi. Genetic Underpinnings of Hybrid Tumors of Adenoid Cystic Carcinoma and Adenomyoepithelioma of the Breast - A Variant of Adenoid Cystic Carcinoma?. MODERN PATHOLOGY. 2020. 33. SUPPL 2. 229-230
- Tomo Osako, Satoko Baba, Hiroko Nagano, Takayuki Ueno, Shinji Ohno, Futoshi Akiyama, Kengo Takeuchi. Genetic Underpinnings of Hybrid Tumors of Adenoid Cystic Carcinoma and Adenomyoepithelioma of the Breast - A Variant of Adenoid Cystic Carcinoma?. LABORATORY INVESTIGATION. 2020. 100. SUPPL 1. 229-230
- 大迫 智, 馬場 郷子, 坂田 征士, 冨樫 由紀, 上野 貴之, 大野 真司, 竹内 賢吾, 秋山 太. 腺様嚢胞癌と腺筋上皮腫の混合型乳腺腫瘍 腺様嚢胞癌の新しい組織亜型か?. 日本病理学会会誌. 2019. 108. 1. 289-289
- 瀬戸 陽, 佐藤 由紀子, 冨樫 由紀, 土橋 映仁, 坂田 征士, 馬場 郷子, 蛯名 彩, 竹内 賢吾, 三谷 浩樹. 頭頸部腺様嚢胞癌 予後因子の解析と、遠隔転移例に対する局所治療についての検討. 日本耳鼻咽喉科学会会報. 2018. 121. 4. 543-543
- 内田士朗, 鈴木高祐, 宇野美恵子, 野嵜史, 阿部江利子, 林透, 佐藤由紀子, 竹内賢吾, 秋山太. 乳腺充実型腺様嚢胞癌と考えられた一例. 日本病理学会会誌. 2017. 106. 1. 491
- 矢田直美, 小川郁子, 佐藤由紀子, 竹内賢吾, 坂口修, 吉賀大午, 冨永和宏, 松尾拡. 頬粘膜腫瘍. 日本臨床口腔病理学会総会・学術大会プログラム・抄録集(Web). 2017. 28th. 56 (WEB ONLY)
- Keisuke Kataoka, Hiroaki Miyoshi, Yasunori Kogure, Yasuharu Sato, Kenji Nishida, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Chiba, Yosaku Watatani, Yusuke Shiozawa, et al. Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas. BLOOD. 2016. 128. 22
- Seok Jin Kim, Hye Jin Kang, Shin Dong-Yeop, Ho Sup Lee, Sung Yong Oh, Ho-Jin Shin, Dok Hyun Yoon, Jung Yong Hong, Jee Hyun Kong, Kana Sakamoto, et al. The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma. BLOOD. 2016. 128. 22
- Yuko Mishima, Masahiro Yokoyama, Noriko Nishimura, Kyoko Ueda, Tadahiro Gunji, Hideaki Nitta, Yoshiharu Kusano, Norihito Inoue, Anna Takahashi, Naoko Tsuyama, et al. R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL. BLOOD. 2015. 126. 23
- Hideaki Nitta, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Noriko Nishimura, Kyoko Ueda, Tadahiro Gunji, Yoshiharu Kusano, Norihito Inoue, Anna Takahashi, et al. The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma. BLOOD. 2015. 126. 23
- Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Hideaki Nitta, Yoshiharu Kusano, Masahiro Yokoyama, Naoko Tsuyama, Yasuhito Terui, Kengo Takeuchi, Oguchi Masahiko, et al. RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens. BLOOD. 2014. 124. 21
- Yoshiharu Kusano, Yasuhito Terui, Noriko Nishimura, Kyoko Ueda, Gunji Tadahiro, Hideaki Nitta, Yuko Mishima, Masahiro Yokoyama, Naoko Tsuyama, Kengo Takeuchi, et al. ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma. BLOOD. 2014. 124. 21
- Aya Ouchi, Yokoyama Masahiro, Masahiko Oguchi, Kengo Takeuchi, Yoshiharu Kusano, Hideaki Nitta, Kyoko Ueda, Noriko Nishimura, Naoko Tsuyama, Yasuhito Terui, et al. Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma ( DLBCL) Cases at a Single Institution. BLOOD. 2014. 124. 21
- 佐藤由紀子, 竹内賢吾, 新橋渉, 佐々木徹, 福島啓文, 米川博之, 三谷浩樹, 川端一嘉, 小松京子, 山本智理子, et al. EWSR1の転座を有する口蓋のhyalinizing clear cell carcinomaの1例. 日本病理学会会誌. 2014. 103. 2. 42-42
- Kana SAKAMOTO, Yuki TOGASHI, Kengo TAKEUCHI. Lung: t(6;12)(q22;q14.1) LRIG3/ROS1 in lung adenocarcinoma. Atlas Genet Cytogenet Oncol Haematol. 2014
- Akira Inoue, Makoto Nishio, Katsuyuki Kiura, Takashi Seto, Kazuhiko Nakagawa, Makoto Maemondo, Toyoaki Hida, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, et al. ONE-YEAR FOLLOW-UP OF A PHASE I/II STUDY OF A HIGHLY SELECTIVE ALK INHIBITOR CH5424802/RO5424802 IN ALK-REARRANGED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). JOURNAL OF THORACIC ONCOLOGY. 2013. 8. S1204-S1204
- Mamiko Sakata-Yanagimoto, Terukazu Enami, Kenichi Yoshida, Yuichi Shiraishi, Ryohei Ishii, Yasuyuki Miyake, Hideharu Muto, Naoko Tsuyama, Yusuke Okuno, Seiji Sakata, et al. Somatic G17V Rhoa Mutation Specifies Angioimmunoblastic T-Cell Lymphoma. BLOOD. 2013. 122. 21
Return to Previous Page
